| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, Member of 10% Owner Group | Director
1 company
John Ackerman is Director, Member of 10% Owner Group at GRDN. John Ackerman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $52.6M at current prices.
Our model assigns John Ackerman a below-average insider score of 14/100, based on 3 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -78.7%.
The GRDN filings lean toward selling, a net 2,388,943 shares.
John Ackerman has 7 Form 4 filings on record from September 2024 to September 2026, all as Director, Member of 10% Owner Group at Guardian Pharmacy Services (GRDN), 2024–2026.
The 16 reported transactions were 8 option exercises, 6 open-market sales and 2 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $58.7M.
The largest open-market sale was 1,103,364 shares of GRDN at an average $29.68 on March 20, 2026, about $32.8M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.